Sort
59,101 grants matching “hypertension”
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
$770,301Alexander P Reiner · Fred Hutchinson Cancer Research Center · R01 · FY2015 · HL
COPD Clinical Research Network
$770,300University Of California San Francisco · U10 · FY2003 · HL
Leveraging a Natural Experiment to Estimate the Effects of School Racial Segregation on Cardiovascular Risk Factors among Youth and Young Adults
$770,274Rita Hamad · University Of California, San Francisco · R01 · FY2021 · HL
Mitochondrial DNA heteroplasmy and risk for atherosclerotic cardiovascular disease (ASCVD)
$770,215Dan E Arking · Johns Hopkins University · R01 · FY2020 · HL
Nighttime Dosing of Anti-Hypertensive Medications: A Pragmatic Clinical Trial
$770,129Gary E Rosenthal · University Of Iowa · UH2 · FY2012 · AT
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethni
$770,072Bryan R Kestenbaum · University Of Washington · R01 · FY2011 · HL
Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk
$770,042James Brian Byrd · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
New York State Component A: BD-STEPS II Core
$770,000Marilyn L. Browne · Center Of Environmental Health · U01 · FY2018 · DD
Novel Mechanisms of Hepatopulmonary Syndrome
$769,998Steven M Kawut · University Of Pennsylvania · R01 · FY2019 · HL
Comparative effectiveness of anti-obesity medications for cardiometabolic health outcomes and health services use
$769,985Darren Toh · Harvard Pilgrim Health Care, Inc. · R01 · FY2024 · HL
Quality of Life and Aging with HIV in Rural Uganda
$769,935Mark J Siedner · Massachusetts General Hospital · R56 · FY2018 · AG
Planned CORR: Planned Care for Obesity and Risk Reduction
$769,846Kevin Patrick · University Of California, San Diego · R01 · FY2009 · HL
Can diet- & exercise-induced weight loss improve asthma control in obese adults?
$769,820Jun Ma · Palo Alto Medical Foundation Res Inst · R01 · FY2010 · HL
Computational Assessment of Galectin-3 Significance in Heart Failure Remodeling
$769,814Siamak Ardekani · Johns Hopkins University · R01 · FY2016 · HL
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
$769,772Elizabeth A Howell · University Of Pennsylvania · R01 · FY2024 · MD
Estrogen signaling and energy metabolism in pulmonary arterial hypertension
$769,744Eric Douglas Austin · Vanderbilt University Medical Center · R01 · FY2020 · HL
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk
$769,588Virend K Somers · Mayo Clinic Rochester · R01 · FY2025 · HL
Hybrid Rat Diversity Program
$769,547Melinda R Dwinell · Medical College Of Wisconsin · R24 · FY2020 · OD
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens
$769,543Joseph C Wu · Stanford University · R01 · FY2025 · HL
Upstream Contributors to Downstream Disparities in Type 2 Diabetes
$769,530John B McKinlay · New England Research Institutes, Inc. · R01 · FY2011 · DK
Novel Mechanisms of Hepatopulmonary Syndrome
$769,513Steven M Kawut · University Of Pennsylvania · R01 · FY2021 · HL
Xenon MRI in Pulmonary Hypertension
$769,506Sudarshan K Rajagopal · Duke University · R01 · FY2022 · HL
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
$769,444William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Studies of the fate of environmental contaminants in humans and animals
$769,352Linda Birnbaum · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes
$769,341Joann M Sperl-Hillen · Healthpartners Institute · R01 · FY2018 · HL